Small molecule · Small-Molecule Compounds
Buy NAD+ for research use from Seqvanta. Choose from 3 published package presentations and review the published presentation before checkout.
Choose your package
NAD+ has 3 published package options. Select the row that matches your requested amount; each price is per package.
At a glance
Before you order
Buy NAD+ for research use from Seqvanta. Package prices run from $60.45-$150.22 USD per package across 3 published package presentations; package content is 100 mg, 500 mg, 1000 mg. Choose the presentation that matches your request, then review quality and shipping notes before checkout.
Product overview
Small molecule · The page presents the compound as a small molecule and does not infer peptide-specific properties.
Identity
NAD+ is kept as a separate material class. Use the identity note below before comparing it with other products.
Before you order
NAD+ is a small-molecule product; confirm its compound identity and analytical requirements before selecting an offer.
Published research
Indexed PubMed records were found for this product name or a registered alias. They are research references, not proof that a specific batch is equivalent or clinically effective.
Indexed animal or in-vivo study; findings are limited to the reported model.
Animal or in-vivo model; not evidence of human safety or efficacy.
Read the paperIndexed cell or in-vitro study; findings do not establish human safety or efficacy.
Cell or in-vitro model; findings do not establish human efficacy or safety.
Read the paperIndexed cell or in-vitro study; findings do not establish human safety or efficacy.
Cell or in-vitro model; findings do not establish human efficacy or safety.
Read the paperIndexed cell or in-vitro study; findings do not establish human safety or efficacy.
Cell or in-vitro model; findings do not establish human efficacy or safety.
Read the paperReview article that summarises earlier work; it does not add a new clinical outcome.
Review article; it summarises prior work rather than adding a new human outcome.
Read the paperIndexed publication linked to this name; verify the exact compound and model in the full paper.
Model type was not explicit in the indexed record; verify the primary paper.
Read the paperRegistered studies
These records describe registered clinical studies. A registration is not the same as a published result.
Documents and checks
The details are grouped by the decision they support. Prices and package choices stay in the purchase panel above.
For NAD+, verify compound identity, analytical method, and unit basis against a batch or analytical document that matches the receiving method. A lot-specific certificate of analysis is not published for NAD+; request the required evidence before payment.
For NAD+, Seqvanta's operational terms are a 24-hour reservation and dispatch within two business days after confirmed payment.
A research-grade or purity decision for NAD+ needs evidence that matches the receiving method. The public page does not turn an absent purity, bioactivity, endotoxin, or grade value into a claim; resolve the compound identity, analytical method, and unit basis questions before relying on this product.
NAD+ confirms the compound identity, package basis, and checkout state: a priced package can be selected now. Analytical release criteria and destination-country review remain separate checks.
Questions before checkout
Answers focus on choosing, verifying and ordering this product.
NAD+ is listed as a small-molecule compound in the Small-Molecule Compounds catalog. The identity status is separate material class; use the published name and package fields rather than extending the page into a sequence, purity, efficacy, or regulatory claim.
Choose the NAD+ row by total content (100 mg, 500 mg, and 1000 mg); confirm the selected row in the cart before payment. A larger package price is not automatically a different formulation.
NAD+ calls for a compound-specific check: unit basis, analytical documentation, and receiving requirements. Do not carry peptide package assumptions into this product.
Use the package comparison above for NAD+: the selectable rows are 100 mg, 500 mg, and 1000 mg / 1 vial. They show content, form, and container on a mg basis; any unpublished field remains unconfirmed for the selected presentation.
The public product page shows the fields that are available for NAD+; any missing SDS, CAS, concentration, or batch document must be requested before payment.
NAD+ has a current published price of $60.45-$150.22 USD per package. Use the package table for the exact row amount; prices are per package, not a concentration or dose.
NAD+ is an active catalog product and currently purchasable: the priced package rows above can be selected in checkout.
SDS / safety data sheet, CAS number, and concentration for NAD+ are not published on the public product page unless a selected row states one. Request the relevant document before payment; do not infer these values from the name or package label.
Species reactivity and authenticity / chain-of-custody verification are not published for NAD+. Request method-specific or batch traceability documentation when your receiving process requires it.
No public supplier reviews or rating are published for NAD+. Evaluate the product against its identity evidence, documentation, and written fulfillment terms.
Commercial terms
Review the package, reservation, and dispatch terms before checkout.
Continue browsing
Contact Seqvanta
Need to confirm the NAD+ package, documents, or delivery? Send the product name and package label through Contact. Use Wholesale for volume or private-label requests.
Contact us